Dr. Simó Schwartz Jr. has been appointed as the new general director of the Blood and Tissue Bank, replacing Dr. Enric Argelagués, who leaves his position today, March 1, after 17 years in the management (1993 – 2002 and 2013 – 2021)...
Read more
Nanomedicine has emerged as a potential therapy for pancreatic cancer, a disease with a 5-year survival rate as low as 5%. The international project NoCanTher was launched in 2016 to test the use of magnetic nanoparticles in treating locally...
Read more
The research group on CIBBIM-Nanomedicine, Drug Delivery and Targeting of the Vall d’Hebron Research Institute (VHIR) has recently participated in a study with the aim of finding a useful treatment to combat colorectal cancer, but also to...
Read more
The creation of BSURE Medical represents the culmination of the valuation and transfer strategy carried out by the VHIR Innovation Unit of a research project of which Dr. Jaume Alijotas Reig and Dr. Simo Schwartz Jr are the main researchers and...
Read more
The membrane of a cell is an effective barrier that makes it difficult to deliver molecules, such as therapeutic compounds, in a targeted manner. In recent years, various strategies have been developed to get the molecules inside the cell, but in...
Read more
The Spanish Association Against Cancer (AECC) presented today, within the framework of World Cancer Research Day, the resolution of the grants to promote research against cancer. Among the selected candidates, there are three researchers working...
Read more
Hepatocellular carcinoma is the most common liver cancer and ranks third in the world in terms of mortality. Its appearance is related to the hepatitis B and C viruses, alcoholism, metabolic diseases of the liver and exposure to certain toxins...
Read more
The CIBBIM-Nanomedicine. Drug Delivery and Targeting Group of the Vall d’Hebron Research Institute (VHIR) has conducted a study to measure the effectiveness of Zileuton ™, a drug that is indicated for the treatment of asthma, administered...
Read more
Researchers from the CIBBIM-Nanomedicine Drug Delivery and Trageting of the Vall d’Hebron Research Institute (VHIR) and CIBER-BBN with Dr. Ibane Abasolo at the head, have studied the viability of the bacterial inclusion bodies as a method...
Read more
The Nanoparticle Design and Pharmacodynamics group focuses on the synthesis, characterisation and applications of inorganic nanoparticle engineering in the field of medicine. The group’s aim is to design nanoparticles that can interact with...
Read more
Yesterday evening, on the occasion of the Biologist’s Day, Dr. Anna Meseguer picked up the Research and Investigation Prize awarded by the College of Biologists of Catalonia in recognition of her contribution to scientific advances and the...
Read more
The Safe-N-Medtech initiative just kicked off last week in Bilbao, in a meeting hosted by Osteba, the HTA Unit of the Health Ministry of the Basque Country (Spain) in collaboration with BIOPRAXIS-BIOKERALTY. The project is coordinated by TECNAN...
Read more
